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Background/Aims: Obesity tends to be associated with 
increased mortality and morbidity in acute pancreatitis. How-
ever, in Asian populations, higher morbidity and mortality 
have been reported in patients with low body mass indexes 
(BMIs). This study was undertaken to evaluate the relation 
between obesity and outcome, and to investigate the occur-
rence of complications by overweightedness in acute pan-
creatitis. Methods: The medical records of 403 patients with 
acute pancreatitis were reviewed retrospectively, and Ran-
son’s scores, modiﬁ  ed Glasgow scores, Acute Physiology and 
Chronic Health Evaluation (APACHE) II scores and computed 
tomography severity indexes were calculated. Patients were 
categorized by BMI for the analysis. Results: When com-
pared with normal patients (BMI 18.5 to 22.9), all categories 
with a BMI ≥23 had an increased risk of developing a severe 
form of acute pancreatitis (p=0.003) and all categories with 
a BMI ≥25 signiﬁ  cantly predicted severity (p<0.001). Patients 
with class 1 obesity (BMI 25 to 29.9) developed signiﬁ  cantly 
more systemic and metabolic complications. Conclusions: 
Overweightedness and obesity were found to be associated 
with a higher risk of developing severe pancreatitis. Further 
studies are needed to establish the precise prognostic value 
of obesity in members of the population with low BMIs. (Gut 
Liver 2011;5:335-339)
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INTRODUCTION
The incidence of acute pancreatitis appears to have increased 
in South Korea,
1 and this increase is attributed to improved 
diagnostic procedures.
2 In the majority of patients, acute pan-
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creatitis is mild. However, in 10% to 20% of patients increased 
intrapancreatic and extrapancreatic inflammation result in what 
is generally referred to as systemic inflammatory response syn-
drome (SIRS). Necrotizing pancreatitis develops in approximate-
ly 10% to 20% of patients and mortality is high (range from 
14% to 25%). About half of these deaths in patients with acute 
pancreatitis occur within the first 1-2 weeks and are mainly at-
tributable to multiple organ dysfunction syndrome (MODS).
3,4 
Hence, early diagnosis and accurate prediction of acute pancre-
atitis severity are important.
Multifactorial scoring systems like Ranson’s prognostic signs, 
the modified Glasgow, and the Acute Physiology and Chronic 
Health Evaluation ** (APACHE II) scoring systems are widely 
used to predict the severity of acute pancreatitis.
5,6 Morbidity 
and mortality associated with acute pancreatitis are substan-
tially higher when necrosis is present, especially when the ne-
crotic region is also infected.
7 Pancreatic necrosis is diagnosed 
radiographically by dynamic intravenous contrast-enhanced 
computed tomography (CT) of the abdomen.
8 However, because 
it is still difficult to establish an immediate prognosis for acute 
pancreatitis, several studies have been conducted to establish 
the prognostic usefulnesses of clinical data easily determined on 
admission, such as, obesity.
9 Recently, several studies have iden-
tified obesity as a negative prognostic factor in acute pancreati-
tis.
10,11 However, in Asian populations, morbidity and mortality 
also occur in patients with low body mass indexes (BMIs). Thus 
Asian studies have failed to demonstrate a meaningful relation 
between obesity and outcome.
12 In the present study, we aimed 
to evaluate the relation between obesity and the severity of 
acute pancreatitis and to investigate the occurrence of compli-
cations in different BMI classes.336  Gut and Liver, Vol. 5, No. 3, September 2011
MATERIALS AND METHODS
From January 2000 to February 2007, 574 patients were 
treated for acute pancreatitis at Kyungpook National University 
Hospital in Daegu, Korea. This retrospective study was con-
ducted on 403 patients with height and body weight details. 
Acute pancreatitis was diagnosed based on the presence of 
typical abdominal pain (the cardinal symptom of acute pancre-
atitis), a serum amylase or lipase levels threefold or more above 
upper normal limit, and abdominal CT scan findings compatible 
acute pancreatitis. We recorded age, gender, height, and body 
weight at admission, pancreatitis etiology, hospital stay, and 
hospitalization time in our intensive care unit. For patients with 
a history of alcohol abuse, pancreatitis was regarded as being 
alcohol induced. Gallstone pancreatitis was diagnosed based on 
a radiologic findings of a gallstone or bile duct dilatation and 
laboratory findings of obstructive jaundice. All patients were 
assessed using Ranson’s, modified Glasgow, and the APACHE 
II scores. Contrast enhanced CT findings were graded using the 
Balthazar-Ranson criteria for severity, and CT severity index 
scores (Balthazar Scoring) were also calculated. Acute pancre-
atitis was classified using the Atlanta consensus classification 
system, and severe pancreatitis was defined as pancreatitis 
associated with organ failure and/or local complications (ne-
crosis, an abscess, or pseudocyst). Organ failure was defined as 
shock (systolic pressure <90 mm Hg), pulmonary insufficiency 
(PaO2 ≤60 mm Hg), renal failure (serum creatinine >2.0 mg/dL 
after hydration), or gastrointestinal bleeding (>500 cc/24 hr). A 
number of additional systemic complications were identified as 
being characteristic of severe acute pancreatitis, these were, dis-
seminated intravascular coagulation (platelets ≤100,000/mm
3, 
fibrinogen ≤100 mg/dL, fibrin split products >80 μg/mL), or a 
severe metabolic disturbance (serum calcium ≤7.5 mg/dL). 
Obesity was classified by BMI, which was calculated as 
weight in kilograms divided by height in meters squared (kg/
m
2). According to the World Health Organization (WHO) West-
ern Pacific Region, we used BMI cutoff points to define a nor-
mal body weight (BMI 18.5 to 22.9 kg/m
2), overweightedness 
(BMI 23 to 24.9 kg/m
2), and an obese state (BMI ≥25 kg/m
2). 
Continuous variables are expressed as means (±SD) and cat-
egorical variables as absolutes and relative frequencies. The sig-
nificances of differences between the distributions of quantita-
tive and qualitative variables were assessed using the Student’s 
t-test or the chi-square test, respectively. SPSS version 12.0 for 
Windows (SPSS Inc., Chicago, IL, USA) was used throughout, 
and p-values of <0.05 were considered statistically significant. 
Non-parametric data was assessed using the Whitney U-test. 
Relationships between obesity and the incidences of complica-
tions were assessed using odds ratios (ORs) with 95% confidence 
intervals (CIs). 
Univariate and multivariate logistic regression analyses were 
used to investigate relations between age, gender and BMI and 
a poor prognosis.
RESULTS
The 29 underweight patients (BMI <18.5 kg/m
2), which in-
cluded 4 cases of severe complications, were excluded. Of the 
remaining 374 patients (BMI ≥18.5 kg/m
2), there were 200 
(53.5%) gallstone pancreatitis patients, 115 (30.7%) alcohol-
induced pancreatitis patients, and 59 (15.8%) patients with other 
etiologies, such as, infections and drugs. In addition, there were 
276 mild pancreatitis patients and 98 severe pancreatitis pa-
Table 1. Characteristics of Patients with Mild and Severe Acute Pan-
creatitis
Variable Mild (n=276) Severe (n=98) p-value
Age, yr 55.8±0.9 54.8±1.6 0.583
Gender, M/F 179/97 79/19 0.004
Etiology (alcohol/stone/etc.) 65/167/44 50/33/15 <0.001
BMI, kg/m
2 23.30±0.18 24.39±0.34 0.007
Ranson’s score* 1.95 (0-6) 3.53 (0-7) <0.001
Modified Glasgow score* 1.39 (0-5) 2.99 (0-5) <0.001
APACHE II score* 5.63 (0-16) 11.11 (0-30) <0.001
CT severity index score* 1.42 (0-4) 3.09 (0-10) <0.001
BMI, body mass index; APACHE, acute physiology and chronic 
health evaluation; CT, computerized tomography. 
*Values expressed in mean (range).
Table 2. Comparison of the Normal Group and the Overweight and 









Age, yr 55.8±1.2 55.3±1.0 0.726
Gender, M/F 121/49 137/67 0.403
Etiology (alcohol/stone/etc.) 51/89/30 64/111/29 0.663
Ranson’s score* 2.18 (0-7) 2.51 (0-7) 0.039
Modified Glasgow score* 1.65 (0-5) 1.94 (0-5) 0.042
APACHE II score* 6.76 (0-21) 7.33 (0-30) 0.230
CT severity index score* 1.69 (0-10) 2.00 (0-10) 0.162
Outcome (severe) 32 66 0.003
  Organ failure 24 34 0.498
  Other complications
    Systemic 10 21 0.123
    Metabolic   9 23 0.040
    Local   9 19 0.141
  Death   1   4 0.250
BMI, body mass index; APACHE, acute physiology and chronic 
health evaluation; CT, computerized tomography.
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tients, 5 of whom died. The characteristics of the patients with 
mild and severe acute pancreatitis are summarized in Table 1. 
The incidence of severe pancreatitis was higher in males (OR, 
2.253; 95% CI, 1.289 to 3.938). However, 62 of the 65 mild al-
cohol-induced patients and all 50 patients with severe alcohol-
induced pancreatitis were male. No significant gender difference 
was found for gallstone pancreatitis (p=0.842). Severe pancre-
atitis developed more frequently in alcohol-induced pancreatitis 
cases than gallstone-induced pancreatitis cases (OR, 3.893; 95% 
CI, 2.303 to 6.579). The mean BMI of severe pancreatitis patients 
was greater than that of mild pancreatitis patients (p=0.007). As 
was expected, severity index scores were also higher in severe 
pancreatitis (p<0.001).
No significant differences in age, gender, and etiology were 
observed between the normal group (BMI 18.5 to 22.9, n=170) 
and the overweight and obese group (BMI ≥23, n=204) group 
(Table 2). In terms of severity index scores, comparing of the 
normal group and the overweight and obesity groups, Ranson’s 
scores were 2.18 and 2.51 (p=0.039), and modified Glasgow 
scores were 1.65 and 1.94 (p=0.042), respectively, but APACHE 
II scores were 6.76 and 7.33 (p=0.230), and CT severity index 
scores were 1.69 and 2.00 (p=0.162), respectively. The incidence 
of a severe outcome was higher in the overweight and obese (BMI 
≥23) group than normal group (p=0.003; OR, 2.063; 95%CI, 
1.272 to 3.345). Metabolic complications developed 5.3% (9/170) 
in the normal group and 11.3% (23/204) in the overweight and 
obesity groups (p=0.040), but organ failure, the incidences of 
systemic and local complications, and death rate were not sig-
nificantly different in both groups.
No significant differences in age, gender, etiology, and sever-
ity index scores were found between the obese group (BMI ≥25, 
n=108) and the normal group (BMI 18.5 to 22.9, n=170) (Table 3). 
The incidence of a severe outcome was higher in the obese (BMI 
≥25) group than in the normal group (p<0.001). Systemic com-
plications were 5.9% (10/170) in the normal group and 13.9% 
(15/108) in the obese group (p=0.023), and metabolic compli-
cations were 5.3% (9/170) and 13.0% (14/108), respectively 
(p=0.024), but organ failure, local complications, and death ratio 
were not significantly different in both groups. The rate of obe-
sity was 44.9% among those that developed severe pancreatitis, 
and in the obese group, the odds ratio of severe pancreatitis was 
2.965 (95% CI, 1.722 to 5.105), of a systemic complication was 
2.581 (95% CI, 1.114 to 5.978), and of a metabolic complication 
was 2.664 (95% CI, 1.110 to 6.392).
In Table 4, we subclassified obesity into two groups, the obese 
I (BMI 25 to 29.9) and obese II groups (BMI ≥30). No significant 
difference in age, gender, or etiology was found between the 
normal, overweight, obese I, obese II groups. The incidence of 
severe pancreatitis was higher in the obese I group (p<0.001; 
OR, 3.026; 95% CI, 1.732 to 5.287), but not in the overweight 
and obese II group. The obese I group had a higher rate of 
systemic complications (p=0.035; OR, 2.476; 95% CI, 1.042 to 
5.885), and metabolic complications (p=0.020; OR, 2.769; 95% 
CI, 1.137 to 6.741) than the normal group. We also performed 
univariate and multivariate logistic regression test to investigate 
Table 3. Comparison of the Normal Group and the Obese Group in 









Age, yr 55.8±1.2 54.1±1.5 0.378
Gender, M/F 121/49 74/34 0.637
Etiology (alcohol/stone/etc) 51/89/30 35/55/18 0.911
Ranson’s score* 2.18 (0-7) 2.42 (0-7) 0.227
Modified Glasgow score* 1.65 (0-5) 1.97 (0-5) 0.064
APACHE II score* 6.76 (0-21) 7.42 (0-30) 0.292
CT severity index score* 1.69 (0-10) 1.87 (0-10) 0.503
Outcome (severe) 32 44 <0.001
  Organ failure 24 21 0.240
  Other complications
    Systemic 10 15 0.023
    Metabolic   9 14 0.024
    Local   9 11 0.124
  Death   1   2 0.320
BMI, body mass index; APACHE, acute physiology and chronic 
health evaluation; CT, computerized tomography.
*Values expressed in mean (range).














No. of patients 170 96 97 11
Age, yr 55.8±1.2 56.6±1.5 54.1±1.6 54.7±5.4
Gender, M/F 121/49 63/33 68/29 6/5
Etiology (alcohol/stone/etc.) 51/89/30 29/56/11 31/51/15 4/4/3
Outcome (severe) 32 22  40*   4
  Organ failure 24 13 19   2
  Other complications
    Systemic 10   6  13*   2
    Metabolic   9   9  13*   1
    Local   9   8   9   2
  Death   1   2   2   0
Length of hospital stay, day 10.1±0.8 11.2±1.3 12.2±1.2 8.7±3.0
Length of ICU stay, day 0.2±0.1 0.6±0.5 0.3±0.3   0
BMI, body mass index; ICU, intensive care unit.
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the prognostic values of age, gender, and BMI, and both gender 
(p=0.004) and BMI (p=0.003) were found to be independent pre-
dictive factors of a poor prognosis.
DISCUSSION
The Atlanta Symposium produced a clinically based clas-
sification system for the definition of acute pancreatitis, its 
severity, and complications.
13 According to this system, severe 
pancreatitis is defined by the presence of organ failure, and or 
local complications that are associated with an increased risk 
of mortality. However, results from recent clinical studies indi-
cate that these complications vary in terms of their effects on 
outcome, and that many are not necessarily life threatening on 
their own.
14 For example, in necrotizing pancreatitis, almost all 
patients with no sign of organ failure survived, but 47% of pa-
tients with multiple organ failure died. 
A recent study showed persistent (>48 hours) organ failure, 
whether present at admission or arising during the first week, 
was significantly associated with a fatal outcome, and also that 
a duration of organ failure predicted severe acute pancreatitis 
and was strongly associated with the risk of death or a local 
complication.
15 In this study, of 254 patients with an APACHE 
II score that remained stationary or decreased at 48 hours after 
admission, 55 patients (21.7%) had a severe outcome, however, 
of 120 patients with an APACHE II score that increased at 48 
hours after admission, 43 patients (35.8%) had a severe out-
come, and an increase in APACHE II score and the severity of 
pancreatitis were found to be significantly related (chi-square, 
p=0.003602; OR, 2.02054; 95% CI, 1.253 to 3.258). Two studies 
have shown that APACHE II score at 48 hours after admission 
is a more useful predictor of severe outcome than APACHE II 
score on admission, and that a deteriorating APACHE II score 
is significantly associated with mortality in patients with severe 
acute pancreatitis.
16,17 
A meta-analysis of all available reports published between 
1965 to December 2002, evaluated a total of 81 obese (BMI ≥30) 
patients and showed that obesity is a prognostic factor of the 
development of systemic and local complications in acute pan-
creatitis; however, but mortality among obese patients was only 
slightly higher.
18 In this study, 46 of 170 patients (27.1%) in the 
normal group showed a deterioration of APACHE II score at 48 
hours after admission, and 74 of 204 patients (36.3%) in the 
overweight and obese group showed deterioration of APACHE II 
score (p=0.057; OR, 1.534; 95% CI, 0.986 to 2.389). 
It has been reported that obesity is associated with a low-
grade inflammatory state,
19 and it has been suggested that this 
inflammatory condition predisposes the development of SIRS 
and organ dysfunction in acute pancreatitis.
20 The occurrence 
of severe pancreatitis in obese patient can also be explained by 
a lot of fat around the pancreas, fat necrosis and the release of 
virulence factors, an excessive inflammatory reaction, reduc-
tion of respiratory motion, formation of infection foci caused by 
necrosis. This led to a proposal that the APACHE II scoring sys-
tem (APACHE-O) be modified to take obesity into account.
21 De 
Waele et al.
22 investigated the occurrence of gallstone pancreati-
tis complications in different BMI classes, and found that num-
bers and severities of complications increased with BMI. In the 
present study, Ranson’s and modified Glasgow scores at admis-
sion in overweight and obese patients were higher than in the 
normal group, and BMI and the severity of acute pancreatitis 
were found to be significantly related (p=0.007). Disease sever-
ity was greater in the obese group (BMI ≥25) that in normal and 
overweight group (p<0.001; OR, 2.699; 95% CI, 1.659 to 4.390), 
but obese II group was similar to obese I group in terms of the 
incidence of severe outcomes and complications. However, this 
was probably because the proportion of obese II patients was 
low in our cohort (2.9%). 
In Asians, the incidence of obesity is lower than in Cauca-
sians and this difference causes biases during statistical analy-
ses. Yeung et al.
23 showed that obesity is not a prognostic factor 
when obesity is very uncommon (2.0%). In the present study, 
the percentage of overweight and obesity patients was 54.5%, 
and that of obese patients (BMI >25 kg/m
2) was 28.9%, which 
contrast to the high percentage reported in the West, where 
typically, 55% to 57% of patients have a BMI of >25.
9,24
Regional Office for the Western Pacific (WPRO), WHO, In-
ternational Association for the Study of Obesity, International 
Obesity Task Force recommend different ranges of cut-offs for 
overweightedness and obesity in the Asian-Pacific region.
12 
Asians contain a greater proportion of fat than Caucasians at 
similar BMI levels, therefore in Asian populations, morbidity 
and mortality occurring among those with a lower BMI.
25,26 Ac-
cordingly, before any decisions are made about the relationship 
between obesity and acute pancreatitis in Asians, further studies 
are required on other anthropometric indexes, such as waist-hip 
ratio.
In this study, the incidence of severe pancreatitis was 26.2%, 
which concurs with a previous report (11.9% to 32.8%).
20,21,23 
The incidence of alcohol-induced pancreatitis was higher in 
males than females, but the risk of acute pancreatitis according 
to the amount of alcohol consumed showed no gender differ-
ence. Finally, severe pancreatitis was more frequent in males (OR, 
2.253; 95% CI, 1.289 to 3.938).
In conclusion, this study shows that both overweightedness 
and obesity and severity indexes at admission portend a higher 
risk of severe pancreatitis. In the overweight and obese group, 
Ranson’s and modified Glasgow scores were significantly more 
elevated than in the normal group and the obese group devel-
oped more complications than the normal group. This study is 
of clinical significance, because few reports have been previous-
ly issued on overweightedness and acute pancreatitis in Asia.Shin KY, et al: Influence of Obesity on the Severity and Clinical Outcome of Acute Pancreatitis  339
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